Yahoo Web Search

Search results

  1. Jun 12, 2024 · BMS chief Christopher Boerner says company is still open to deals after spending more than $20B on M&A last year

  2. Jun 11, 2024 · Chris Boerner, CEO of Bristol-Myers Squibb, discusses the company's recent performance, strategic initiatives, and future growth opportunities at the...

  3. 16 hours ago · It is also the second major acquisition by BMS under recently appointed chief executive Chris Boerner, who took over the leadership of the company in October. Last week, BMS announced a $14...

  4. 5 days ago · When Sanders asked Chris Boerner, CEO of Bristol Myers Squibb, whether the company would reduce the price of Eliquis, a blood thinner, in the United States to the same level as in Canada, the...

  5. Jun 17, 2024 · The hearing figures to pose questions similar to those raised in February when CEOs from Bristol Myers Squibb (Chris Boerner), Johnson & Johnson (Joaquin Duato) and Merck (Rob Davis) appeared...

    • Kevin Dunleavy
  6. Jun 12, 2024 · Bristol Myers Squibb, for example, posted a series of photos in early June showing CEO Chris Boerner helping to raise a pride flag to fly underneath BMS’ own banner.

  7. Jun 20, 2024 · Latest News. June 21, 2024. Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC) June 21, 2024.